MediWound Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	44.65	4.8	9.16	11.87	33.9	11.05
Short-Term Investments	-	48.34	34.01	29.84	0	-
Cash & Short-Term Investments	44.65	53.14	43.16	41.71	33.9	11.05
Cash Growth	16.67%	23.12%	3.48%	23.05%	206.85%	-48.82%
Accounts Receivable	2.75	1.62	4.8	-	9.33	-
Other Receivables	-	1.11	1.51	1.44	0.65	0.93
Total Trade Receivables	2.75	2.73	6.31	1.44	9.98	0.93
Inventory	4.77	4.09	2.69	2.85	1.96	1.2
Other Current Assets	-	0.03	-	0.23	-	0.47
Total Current Assets	52.17	59.96	52.16	49.7	45.84	14.95
Net Property, Plant & Equipment	27.33	25.79	20.8	15.93	3.58	4.03
Other Intangible Assets	0.02	0.03	0.1	0.17	0.23	0.3
Other Long-Term Assets	0.47	0.44	0.44	0.44	0.36	-
Total Assets	79.98	86.26	73.5	66.46	50.02	19.74
Accounts Payable	7.41	7.65	5.28	5.53	5.66	4.69
Accrued Expenses	5.59	4.53	3.56	3.89	4.16	3.62
Current Portion of Long-Term Debt	0.93	0.87	0.61	1.41	2.24	2.41
Other Current Liabilities	7.72	-	-	-	-	-
Total Current Liabilities	21.65	25.71	26.54	18.13	12.06	10.72
Long-Term Leases	8.13	8.15	6.51	6.35	0.85	1.39
Other Long-Term Liabilities	8.79	21.42	26.38	17.69	26.2	12.21
Total Long-Term Liabilities	16.91	16.92	15.8	16.74	27.05	13.61
Total Liabilities	38.56	42.62	42.34	34.86	39.1	24.33
Common Stock	-	0.26	0.22	0.18	0.14	0.08
Additional Paid-in Capital	-	272.33	236	206.25	178.88	143.87
Accumulated Other Comprehensive Income	-	-0.03	-0.01	-0.02	-0.01	-0.02
Retained Earnings	-	-228.93	-205.05	-174.82	-168.11	-148.51
Shareholders' Equity	41.42	43.63	31.15	31.6	10.91	-4.58
Total Liabilities & Equity	79.98	86.26	73.5	66.46	50.02	19.74
Total Debt	9.06	9.02	7.13	7.76	3.09	3.8
Net Cash (Debt)	35.59	44.12	36.04	33.95	30.81	7.25
Net Cash Growth	-19.33%	22.43%	6.15%	10.20%	325.10%	-58.41%
Net Cash Per Share	2.99	3.88	3.62	3.77	6.18	1.86
Book Value	41.42	43.63	31.15	31.6	10.91	-4.58
Book Value Per Share	3.48	3.84	3.13	3.51	2.19	-1.18
Tangible Book Value	41.41	43.6	31.05	31.43	10.68	-4.88
Tangible Book Value Per Share	3.48	3.83	3.12	3.49	2.14	-1.25

SEC Filings: 10-K · 10-Q